Pharmaceutical

Cristália signs licensing deal for Formosa’s APP13007

Cristália has signed an agreement to license exclusive rights to market Formosa Pharmaceuticals’ APP13007 in Brazil.

Jan 29, 2024 - 18:00
Cristália signs licensing deal for Formosa’s APP13007
Cristália has signed an agreement to license exclusive rights to market Formosa Pharmaceuticals’ APP13007 in Brazil.
Read the original article

Tags:

Previous Article

Cell and gene therapies – top pharmaceutical industry trend to watch for 2024

Next Article

FDA grants priority review for Daiichi Sankyo-AstraZeneca’s Enhertu

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: AI leaders issue a plea to Congress: Regulate us, and quickly

STAT+: AI leaders issue a plea to Congress: Regulate us...

May 17, 2023

J&J expands global access to TB drug as popular novelist joins advocacy campaign

J&J expands global access to TB drug as popular novelis...

Jul 14, 2023

STAT+: Former FDA official lays out how to keep patients safe from risky medical devices

STAT+: Former FDA official lays out how to keep patient...

Oct 2, 2023